Shares of Medical Properties Trust, Inc. (NYSE:MPW) have earned a consensus rating of “Hold” from the ten analysts that are currently covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12-month target price among analysts that have covered the stock in the last year is $16.75.
A number of research analysts recently issued reports on the stock. JPMorgan Chase & Co. upgraded shares of Medical Properties Trust from a “neutral” rating to an “overweight” rating in a research report on Wednesday, December 19th. Jefferies Financial Group upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and boosted their target price for the company from $18.00 to $23.00 in a research report on Wednesday, February 13th. Wells Fargo & Co upgraded shares of Medical Properties Trust from an “underperform” rating to a “market perform” rating and boosted their target price for the company from $13.50 to $17.50 in a research report on Tuesday, December 11th. Mitsubishi UFJ Financial Group boosted their target price on shares of Medical Properties Trust to $17.00 and gave the company a “neutral” rating in a research report on Monday, February 11th. Finally, SunTrust Banks downgraded shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a research report on Tuesday, December 18th.
NYSE MPW opened at $18.24 on Friday. The firm has a market cap of $6.85 billion, a P/E ratio of 13.31, a price-to-earnings-growth ratio of 3.35 and a beta of 0.72. Medical Properties Trust has a 1 year low of $12.24 and a 1 year high of $18.56. The company has a debt-to-equity ratio of 0.89, a current ratio of 5.22 and a quick ratio of 4.92.
Medical Properties Trust (NYSE:MPW) last posted its earnings results on Thursday, February 7th. The real estate investment trust reported $0.31 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.31. The company had revenue of $180.60 million during the quarter, compared to the consensus estimate of $179.68 million. Medical Properties Trust had a net margin of 129.59% and a return on equity of 8.83%. The firm’s quarterly revenue was down 11.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.37 earnings per share. On average, equities analysts predict that Medical Properties Trust will post 1.43 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 11th. Shareholders of record on Thursday, March 14th will be given a $0.25 dividend. The ex-dividend date of this dividend is Wednesday, March 13th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.48%. Medical Properties Trust’s dividend payout ratio (DPR) is currently 72.99%.
In other Medical Properties Trust news, insider Emmett E. Mclean sold 50,000 shares of the company’s stock in a transaction dated Tuesday, December 4th. The shares were sold at an average price of $17.40, for a total value of $870,000.00. Following the completion of the transaction, the insider now owns 913,965 shares in the company, valued at $15,902,991. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Edward K. Aldag, Jr. sold 43,065 shares of the company’s stock in a transaction dated Wednesday, November 28th. The stock was sold at an average price of $16.78, for a total transaction of $722,630.70. Following the completion of the transaction, the chief executive officer now owns 1,873,541 shares of the company’s stock, valued at approximately $31,438,017.98. The disclosure for this sale can be found here. In the last quarter, insiders sold 116,865 shares of company stock valued at $2,024,153. Insiders own 0.83% of the company’s stock.
Institutional investors have recently modified their holdings of the business. Oregon Public Employees Retirement Fund increased its stake in shares of Medical Properties Trust by 1,508.0% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 2,317,289 shares of the real estate investment trust’s stock worth $144,000 after purchasing an additional 2,173,179 shares in the last quarter. Prudential Financial Inc. increased its stake in shares of Medical Properties Trust by 174.1% during the fourth quarter. Prudential Financial Inc. now owns 3,291,582 shares of the real estate investment trust’s stock worth $52,928,000 after purchasing an additional 2,090,516 shares in the last quarter. FMR LLC increased its stake in shares of Medical Properties Trust by 96.7% during the third quarter. FMR LLC now owns 3,876,161 shares of the real estate investment trust’s stock worth $57,793,000 after purchasing an additional 1,905,961 shares in the last quarter. Bank of America Corp DE increased its stake in shares of Medical Properties Trust by 75.3% during the fourth quarter. Bank of America Corp DE now owns 3,264,646 shares of the real estate investment trust’s stock worth $52,495,000 after purchasing an additional 1,402,433 shares in the last quarter. Finally, Lord Abbett & CO. LLC purchased a new stake in shares of Medical Properties Trust during the fourth quarter worth about $20,663,000. Institutional investors and hedge funds own 76.94% of the company’s stock.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Featured Article: Investing strategies using the yield curve
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.